Ido1 Mouse shRNA Plasmid (Locus ID 15930)
CAT#: TL511273
Ido1 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 5,740.00
货期*
现货
规格
Cited in 1 publication. |
经常一起买 (4)
Lateral flow testing sticks used for the semi-quantitative detection of the lentiviral p24 protein, 20 tests
CNY 4,070.00
Specifications
Product Data | |
Product Name | Ido1 Mouse shRNA Plasmid (Locus ID 15930) |
Locus ID | 15930 |
UniProt ID | P28776 |
Synonyms | Ido; Indo |
Vector | pGFP-C-shLenti |
Format | Lentiviral plasmids |
Kit Components | Ido1 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector(Gene ID = 15930). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-C-shLenti Vector, TR30021, included for free. |
RefSeq | BC049931, NM_001293690, NM_008324, NM_008324.1, NM_008324.2, NM_001293690.1 |
Summary | Catalyzes the first and rate limiting step of the catabolism of the essential amino acid tryptophan along the kynurenine pathway. Involved in the peripheral immune tolerance, contributing to maintain homeostasis by preventing autoimmunity or immunopathology that would result from uncontrolled and overreacting immune responses. Tryptophan shortage inhibits T lymphocytes division and accumulation of tryptophan catabolites induces T-cell apoptosis and differentiation of regulatory T-cells. Acts as a suppressor of anti-tumor immunity (PubMed:25691885). Limits the growth of intracellular pathogens by depriving tryptophan. Protects the fetus from maternal immune rejection (Ref. 3).[UniProtKB/Swiss-Prot Function] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (1)
The use of this RNAi has been cited in the following citations: |
---|
Tumor-Repopulating Cells Induce PD-1 Expression in CD8+T Cells by Transferring Kynurenine and AhR Activation
,Liu, Y;Liang, X;Dong, W;Fang, Y;Lv, J;Zhang, T;Fiskesund, R;Xie, J;Liu, J;Yin, X;Jin, X;Chen, D;Tang, K;Ma, J;Zhang, H;Yu, J;Yan, J;Liang, H;Mo, S;Cheng, F;Zhou, Y;Zhang, H;Wang, J;Li, J;Chen, Y;Cui, B;Hu, ZW;Cao, X;Xiao-Feng Qin, F;Huang, B;,
Cancer Cell
,PubMed ID 29533786
[IDO1]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...